Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Repaglinide

Repaglinide Range

Comprehensive Repaglinide portfolio for Franchise & Manufacturing.

Category
repaglinide
Total Formulations
5
Available Forms
Tablets
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Repaglinide portfolio by Dosage Form

Tablets

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Repaglinide batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Repaglinide PCD Pharma Franchise Company

Repaglinide PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Repaglinide PCD pharma franchise company offering a focused portfolio of 5 Repaglinide formulations manufactured under WHO-GMP certified facilities. We support distributors and franchise associates across India who want a reliable supply of quality anti-diabetic products backed by strong promotional inputs.

What is Repaglinide?

Repaglinide is a short-acting meglitinide class oral anti-diabetic agent. It stimulates the pancreas to release insulin in response to a meal, helping control the rise in blood glucose that follows eating. It is usually taken shortly before main meals for type 2 diabetes and may be used alone or with other agents such as metformin. Learn more via PubChem.

Available Repaglinide Formulations

Our current Repaglinide range covers 5 formulations available in the following dosage form: Tablets. Each batch is quality tested to support consistent mealtime glucose control for patients managed by our franchise partners.

Therapeutic Applications

Repaglinide is prescribed for type 2 diabetes, particularly to manage postprandial hyperglycaemia and for patients with irregular meal patterns. It is commonly recommended by diabetologists, endocrinologists and general physicians handling long-term metabolic care.

Why Repaglinide is a High-Potential Molecule for Distributors

Its rapid onset and short duration make Repaglinide a flexible option for patients whose meal timing varies, a real advantage in everyday practice. With diabetes prevalence rising across India, this differentiated mealtime therapy gives franchise partners a valuable addition to their diabetes care basket and supports repeat prescriptions.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations and comprehensive promotional inputs. With more than 1000 franchise partners, we provide reliable supply, transparent pricing and marketing support to help you build a sustainable Repaglinide business.

References

  1. PubChem - Repaglinide
  2. PubMed - Repaglinide Research

Aceclofenac in Modern Clinical Practice

Our formulations of Repaglinide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Repaglinide in PCD Franchise

Start Your Repaglinide Franchise with Cafoli Lifecare

Ready to launch your Repaglinide PCD franchise? Call us at 9518447302 or email info@cafoli.in to secure district-wise monopoly rights in your territory today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

We currently offer 5 Repaglinide formulations in tablet form, all manufactured under WHO-GMP certified facilities.

Yes, we grant district-wise monopoly rights so partners can market Repaglinide exclusively in their allotted territory.

Repaglinide is prescribed by diabetologists, endocrinologists and general physicians managing type 2 diabetes.

Repaglinide is a short-acting meglitinide that stimulates insulin release around meals to control post-meal blood sugar in type 2 diabetes.

A valid Drug License and GST registration are required to partner with Cafoli Lifecare for a Repaglinide franchise.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited